Ackermans & Van Haaren NV (ACKB.BR)
- Previous Close
159.50 - Open
159.20 - Bid --
- Ask --
- Day's Range
157.90 - 160.10 - 52 Week Range
135.70 - 163.90 - Volume
20,134 - Avg. Volume
22,815 - Market Cap (intraday)
5.193B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
13.03 - EPS (TTM)
12.12 - Earnings Date Feb 29, 2024
- Forward Dividend & Yield 3.40 (2.13%)
- Ex-Dividend Date May 30, 2024
- 1y Target Est
186.40
Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate and senior care, and energy and resources businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; specialized advisory banking services for entrepreneurs and liberal professionals; and financing and financial leasing of cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and develops residential, and retail and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital provides engineering and solutions in production process automation; validation and compliance services; production and sale of compact biogas installations; manufactures and supplies specialty chemicals; provides broadcast and media solutions; online and printed news; logistics for rail and road transport, and intermodal transport, and warehousing services; develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, and distribution of aftermarket products. This segment also develops medical devices; medicines for the treatment of cancer and genetic diseases; and supplies medical equipment and consumables to hospitals through online. The company was founded in 1876 and is based in Antwerp, Belgium.
www.avh.be21,887
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ACKB.BR
Performance Overview: ACKB.BR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACKB.BR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACKB.BR
Valuation Measures
Market Cap
5.22B
Enterprise Value
11.83B
Trailing P/E
13.16
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.01
Price/Book (mrq)
1.06
Enterprise Value/Revenue
2.27
Enterprise Value/EBITDA
11.23
Financial Highlights
Profitability and Income Statement
Profit Margin
7.64%
Return on Assets (ttm)
1.75%
Return on Equity (ttm)
8.19%
Revenue (ttm)
5.22B
Net Income Avi to Common (ttm)
399.19M
Diluted EPS (ttm)
12.12
Balance Sheet and Cash Flow
Total Cash (mrq)
1.58B
Total Debt/Equity (mrq)
33.36%
Levered Free Cash Flow (ttm)
36.61M
Research Analysis: ACKB.BR
Company Insights: ACKB.BR
ACKB.BR does not have Company Insights